Urothelial Bladder Cancer
7 clinical trials · Condition
◉ Watch Urothelial Bladder Cancer
| Record | Firm | Date |
|---|---|---|
| Longitudinal Bladder Cancer Study for Tumour Recurrence (NCT05080998) | Pacific Edge Limited | 2022-06-08 |
| Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (NCT04779151) | Gustave Roussy, Cancer Campus, Grand Paris | 2021-04-07 |
| Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy (NCT04428554) | Institut Claudius Regaud | 2020-06-30 |
| Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations (NCT04197986) | QED Therapeutics, a BridgeBio company | 2020-03-11 |
| Study of Tremelimumab in Patients With Advanced Solid Tumors (NCT02527434) | AstraZeneca | 2015-11-02 |
Track Urothelial Bladder Cancer automatically
Every clearance here is in the API, with alerts when new ones post.